Pharmacological inhibition of CPT1A results in impaired cancer cell proliferation in acute myeloid leukemia and intensive cytotoxicity in Burkitts lymphoma 23,32
The front staff was also great
Protective effects of tartary buckwheat flavonoids on high TMAO diet-induced vascular dysfunction and liver injury in mice
Stanford Medicine endocrinologist Sun Kim, MD, MS, and bariatric and minimally invasive surgeon Dan Azagury, MD, FACS, explain how these medications work, who may or may not benefit, the potential benefits and risks, and why they're not a one-size-fits-all solution
Current Evidence on GLP-1 Agonists and Cancer Risk The relationship between GLP-1 agonists and cancer risk, including lymphoproliferative disorders, has been the subject of ongoing pharmacovigilance and clinical research